Health Catalyst, Inc. (HCAT) Guidance & Earnings Results

On 2026-08-06 Health Catalyst, Inc. reaffirmed guidance: "Q3 2026 revenue $55-56M, Adjusted EBITDA $0-0.5M; FY2026 revenue $246-249M, Adjusted EBITDA…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

HCATHealth Catalyst, Inc.Follow HCAT — free

Health Information Services · Healthcare

—

Price chart with a free account

Market cap: 127.2M
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 10 Nov, in 17 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
6 Aug 26	Reaffirmed	Q3 2026 revenue $55-56M, Adjusted EBITDA $0-0.5M; FY2026 revenue $246-249M, Adjusted EBITDA $18-18.5M · full year
11 May 26	—	Q2 2026 revenue $68M-$70M, adjusted EBITDA $9M-$10M; FY26 revenue $260M-$265M, adjusted EBITDA $30M-$33M · full year
12 Mar 26	Reaffirmed	Q1 2026 revenue $68-70M; Q1 2026 Adjusted EBITDA $7-8M
12 Jan 26	Raised	FY2025 revenue slightly above ~$310M; Adj. EBITDA ~$41M; FY2026 bookings expected to exceed 2025. · full year
10 Nov 25	Reaffirmed	Q4 2025: total revenue ~$73.5M, Adjusted EBITDA ~$13.4M; FY2025: total revenue ~$310M, Adjusted EBITDA ~$41M · full year
7 Aug 25	Reaffirmed	Q3 2025: Total revenue ~$75M, Adjusted EBITDA ~$10.5M; FY2025: Total revenue ~$310M, Adjusted EBITDA ~$41M · full year

Health Catalyst, Inc. — questions

What guidance did Health Catalyst, Inc. give?: On 2026-08-06: "Q3 2026 revenue $55-56M, Adjusted EBITDA $0-0.5M; FY2026 revenue $246-249M, Adjusted EBITDA $18-18.5M"
When does Health Catalyst, Inc. report earnings?: Health Catalyst, Inc.'s next earnings report is expected on 2026-11-10.

Every figure on this page comes from Health Catalyst, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.